306 related articles for article (PubMed ID: 31833063)
1. Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection.
Li H; Kilgallen AB; Münzel T; Wolf E; Lecour S; Schulz R; Daiber A; Van Laake LW
Br J Pharmacol; 2020 Dec; 177(23):5393-5412. PubMed ID: 31833063
[TBL] [Abstract][Full Text] [Related]
2. Redox Regulatory Changes of Circadian Rhythm by the Environmental Risk Factors Traffic Noise and Air Pollution.
Daiber A; Frenis K; Kuntic M; Li H; Wolf E; Kilgallen AB; Lecour S; Van Laake LW; Schulz R; Hahad O; Münzel T
Antioxid Redox Signal; 2022 Oct; 37(10-12):679-703. PubMed ID: 35088601
[No Abstract] [Full Text] [Related]
3. The "exposome" concept - how environmental risk factors influence cardiovascular health.
Daiber A; Lelieveld J; Steven S; Oelze M; Kröller-Schön S; Sørensen M; Münzel T
Acta Biochim Pol; 2019 Sep; 66(3):269-283. PubMed ID: 31509369
[TBL] [Abstract][Full Text] [Related]
4. Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.
Bencsik P; Gömöri K; Szabados T; Sántha P; Helyes Z; Jancsó G; Ferdinandy P; Görbe A
Br J Pharmacol; 2020 Dec; 177(23):5336-5356. PubMed ID: 32059259
[TBL] [Abstract][Full Text] [Related]
5. Ageing, sex, and cardioprotection.
Ruiz-Meana M; Boengler K; Garcia-Dorado D; Hausenloy DJ; Kaambre T; Kararigas G; Perrino C; Schulz R; Ytrehus K
Br J Pharmacol; 2020 Dec; 177(23):5270-5286. PubMed ID: 31863453
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection in right heart failure.
Boengler K; Schlüter KD; Schermuly RT; Schulz R
Br J Pharmacol; 2020 Dec; 177(23):5413-5431. PubMed ID: 31995639
[TBL] [Abstract][Full Text] [Related]
7. Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?
Kleinbongard P; Bøtker HE; Ovize M; Hausenloy DJ; Heusch G
Br J Pharmacol; 2020 Dec; 177(23):5252-5269. PubMed ID: 31430831
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory diseases, myocardial function and cardioprotection.
Lazou A; Ikonomidis I; Bartekova M; Benedek T; Makavos G; Palioura D; Cabrera Fuentes H; Andreadou I
Br J Pharmacol; 2020 Dec; 177(23):5357-5374. PubMed ID: 31943142
[TBL] [Abstract][Full Text] [Related]
9. The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols.
Man AWC; Xia N; Daiber A; Li H
Br J Pharmacol; 2020 Mar; 177(6):1278-1293. PubMed ID: 31465555
[TBL] [Abstract][Full Text] [Related]
10. Hyperlipidaemia and cardioprotection: Animal models for translational studies.
Andreadou I; Schulz R; Badimon L; Adameová A; Kleinbongard P; Lecour S; Nikolaou PE; Falcão-Pires I; Vilahur G; Woudberg N; Heusch G; Ferdinandy P
Br J Pharmacol; 2020 Dec; 177(23):5287-5311. PubMed ID: 31769007
[TBL] [Abstract][Full Text] [Related]
11. The role of chemokines and chemokine receptors in pulmonary arterial hypertension.
Mamazhakypov A; Viswanathan G; Lawrie A; Schermuly RT; Rajagopal S
Br J Pharmacol; 2021 Jan; 178(1):72-89. PubMed ID: 31399998
[TBL] [Abstract][Full Text] [Related]
12. Current and future treatments of pulmonary arterial hypertension.
Sommer N; Ghofrani HA; Pak O; Bonnet S; Provencher S; Sitbon O; Rosenkranz S; Hoeper MM; Kiely DG
Br J Pharmacol; 2021 Jan; 178(1):6-30. PubMed ID: 32034759
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological basis and new insights of resveratrol action in the cardiovascular system.
Cheng CK; Luo JY; Lau CW; Chen ZY; Tian XY; Huang Y
Br J Pharmacol; 2020 Mar; 177(6):1258-1277. PubMed ID: 31347157
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of oxidative stress: translational opportunities.
Daiber A; Di Lisa F; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1511-1513. PubMed ID: 28555779
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in chronic obstructive pulmonary disease.
Gredic M; Blanco I; Kovacs G; Helyes Z; Ferdinandy P; Olschewski H; Barberà JA; Weissmann N
Br J Pharmacol; 2021 Jan; 178(1):132-151. PubMed ID: 31976545
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Lazou A; Görbe A; Giricz Z; Schulz R; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1555-1569. PubMed ID: 28060997
[TBL] [Abstract][Full Text] [Related]
17. Kinases as potential targets for treatment of pulmonary hypertension and right ventricular dysfunction.
Weiss A; Boehm M; Egemnazarov B; Grimminger F; Savai Pullamsetti S; Kwapiszewska G; Schermuly RT
Br J Pharmacol; 2021 Jan; 178(1):31-53. PubMed ID: 31709514
[TBL] [Abstract][Full Text] [Related]
18. Right heart failure in pulmonary hypertension: Diagnosis and new perspectives on vascular and direct right ventricular treatment.
Tello K; Seeger W; Naeije R; Vanderpool R; Ghofrani HA; Richter M; Tedford RJ; Bogaard HJ
Br J Pharmacol; 2021 Jan; 178(1):90-107. PubMed ID: 31517994
[TBL] [Abstract][Full Text] [Related]
19. Environmental Stressors and Their Impact on Health and Disease with Focus on Oxidative Stress.
Münzel T; Daiber A
Antioxid Redox Signal; 2018 Mar; 28(9):735-740. PubMed ID: 29278923
[TBL] [Abstract][Full Text] [Related]
20. Environmental noise induces the release of stress hormones and inflammatory signaling molecules leading to oxidative stress and vascular dysfunction-Signatures of the internal exposome.
Daiber A; Kröller-Schön S; Frenis K; Oelze M; Kalinovic S; Vujacic-Mirski K; Kuntic M; Bayo Jimenez MT; Helmstädter J; Steven S; Korac B; Münzel T
Biofactors; 2019 Jul; 45(4):495-506. PubMed ID: 30937979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
